Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
sodium valproate + sirolimus + calcitriol
- Development stage
- Unknown
- Lead developer
- Chinese PLA General Hospital
- Modality
- Small Molecules
- Administration
- Oral
01
Overview
sodium valproate + sirolimus + calcitriol is an experimental combination therapy being investigated for the treatment of severe hemophilia A and B. Developed by Xue-chun Lu at the PLA General Hospital, the regimen consists of oral sodium valproate (an extended-release histone deacetylase inhibitor), sirolimus (an mTOR inhibitor and immunosuppressant), and calcitriol (a Vitamin D receptor agonist). The combination is hypothesized to improve clinical outcomes in severe hemophilia patients, potentially by modulating the immune system to prevent inhibitor formation or by epigenetically upregulating endogenous clotting factor production. It is currently being evaluated in a Phase 1/2 clinical trial to determine its efficacy and safety as an adjunct to primary treatment.
- Other names
- Combination Regimen for Severe Hemophilia
02
Targets
mTOR (Mammalian target of rapamycin kinase)NaV (Voltage-gated sodium channels)HDAC (HDAC family)VDR (Vitamin D receptor)ABAT (4-aminobutyrate aminotransferase)
Beyond the preview
Go deeper on sodium valproate + sirolimus + calcitriol.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Full profile accessExplore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Full profile accessTrace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Full profile accessExplore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Full profile accessCompare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Full profile accessConnect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on sodium valproate + sirolimus + calcitriol.